CMPS

Compass Pathways Plc

A British biotechnology company developing psilocybin-based therapies for mental health conditions, best known for its investigational drug COMP360, a synthetic form of psilocybin given alongside psychological support. It was founded in 2016 by George Goldsmith, Ekaterina Malievskaia, and Lars Christian Wilde, who were inspired after struggling to find effective treatment for a family member's treatment-resistant mental illness. The name reflects the founders' aim to give patients a "compass" to navigate the mental health system, and it was the first psychedelic-medicine company to list on the NASDAQ.

ADRUnderlying: CMPSCUSIP: 20451W101HealthcareGB2 holders

Sponsored American Depositary Receipt

Ownership Activity Financials Filings

Insiders

Ranked by how much each holding moved in the last 3 years

Goldsmith George Jay10% owner · 47 transactions

14.18M—

as of Oct 2024

Sold 2.22M

Malievskaia Ekaterina10% owner · 47 transactions

14.18M—

as of Oct 2024

Sold 2.22M

ATAI Life Sciences AG +1 co-filer10% owner · 1 transaction

6.91M-27.8%

as of Sep 2024

Sold 2.66M

Nath KabirChief Executive Officer, Director · 9 transactions

367.0K+428.8%

Granted 359.0K

Loxam TeriChief Financial Officer · 6 transactions

152.0K—

Granted 162.7K

Owens Matthew AGeneral Counsel & CLO · 3 transactions

43.3K+101.5%

as of Feb 2024

Granted 25.0K

Jenkins AnnalisaDirector · 4 transactions

19.5K-3.4%

as of Aug 2024

Insider	Stake change	Holds now	Granted / vested	Bought	Sold
Goldsmith George Jay10% owner · 47 transactions	—	14.18Mas of Oct 2024	—	—	2.22M
Malievskaia Ekaterina10% owner · 47 transactions	—	14.18Mas of Oct 2024	—	—	2.22M
ATAI Life Sciences AG +1 co-filer10% owner · 1 transaction	-27.8%	6.91Mas of Sep 2024	—	—	2.66M
Nath KabirChief Executive Officer, Director · 9 transactions	+428.8%	367.0K	359.0K	—	—
Loxam TeriChief Financial Officer · 6 transactions	—	152.0K	162.7K	—	—
Owens Matthew AGeneral Counsel & CLO · 3 transactions	+101.5%	43.3Kas of Feb 2024	25.0K	—	—
Jenkins AnnalisaDirector · 4 transactions	-3.4%	19.5Kas of Aug 2024	—	—	—

Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.